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It is well established  that  certain  bacterial  products  may alter non-specific 
defense  mechanisms  of  the  host  (1,  2).  Many  examples  have  been  described 
of a  rapid and transient  increase in resistance to experimental infection follow- 
ing the injection  of killed bacteria  (3-5)  and bacterial products  (5).  However, 
the  identity  or  character  of  the  bacterial  constituents  responsible  for  this 
non-specific immunity has not been clearly defined,  nor has the  mechanism of 
this early resistance  been elucidated.  It is clear that it is not associated with de- 
tectable antibody formation. 
The intravenous injection of cell walls of Escherichia coli and Salmonella typkimu- 
rium  (6)  evokes in mice this type of resistance  to intraperitoneal challenge  with E. 
coll. Zymosan  (7),  an  insoluble  carbohydrate  derived  from cell walls  of yeast, pro- 
duces  a  similar  resistance  against  a  variety of  Gram-negative pathogens  (6,8-10). 
Bacterial  cell  walls,  and  zymosan,  also  combine  with  properdin  in  vitro (11,  12) 
and  alter  serum properdin  levels in vivo (9).  Evidence  now  suggests  that  a  rela- 
tionship  exists  between  the  serum  properdin  levels  of  various  animals  and  their 
resistance  or  susceptibility  to  certain  experimental  or natural  infections. The pro- 
perdin  system  (11),  which consists of properdin,  complement,  and  magnesium,  kills 
or inactivates  a  variety of  infectious  agents in vitro and  appears to be a  factor in 
natural  resistance. 
It  has  been  shown  that  a  purified,  protein-free  lipopolysaccharide  (endotoxin) 
derived  from S.  typhosa  (13),  combines with  properdin  in vitro (12).  The  injection 
in mice of a  large amount  (100 #g.)  of this material causes a  fall in  their properdin 
titers  during  the  first  12  to 24  hours;  this  drop  is followed by an  increase in  titer 
which persists for 96  to  120 hours  (12).  Recently,  it was reported  (14)  that a  small 
amount  (0.1  to  10 #g.)  of a  variety of bacterial  lipopolysaccharides  evokes in mice 
a  rapidly developing, non-specific,  transient,  increase in  resistance  to infection with 
various  Gram-negative pathogens. 
* This investigation  was conducted  under the auspices of the Commission  on  Immuniza- 
tion, Armed Forces Epidemiological  Board, and  was supported in part  by the  Office of the 
Surgeon General, Department of the Army, Washington,  D. C. 
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To resolve and integrate certain aspects of the aforementioned experimental 
work,  it  was  felt  that  two  issues  had  to  be  clarified  further:  first,  the  in- 
fluence of such factors as time between injection and obtaining the blood sam- 
pie,  the  character  of the  bacterial  product,  and  the  dose  employed,  on  the 
nature,  magnitude,  and  duration  of  the  properdin  response;  and  secondly, 
whether  the elevated properdin  titers  reflect  the ability  of the host  to resist 
Gram-negative infections. 
The present work is concerned with the first of these two issues and shows 
that  the dose of Hpopolysaccharide and the interval from time of administra- 
tion affect the degree to which these levels of properdin are increased.  These 
alterations  in properdin levels are also accompanied by the appearance in the 
serum of substances of endogenous origin; these are complex materials of high 
molecular weight. 
The  second  issue,  v/z.  the  relationship  of  these  findings  to  resistance  to 
infection,  is  the  subject  of  a  forthcoming  report  (15)  in  which  it  is  shown 
that the level of serum properdin during the infectious process appears  to be 
of greater significance than the titer at the time of initiation of infection. 
Materials and Methods 
Bacterial Lipopolysaccharidesl.--The lipopolysaccharide derived from Salmonella typhosa 
0901 by the isolation procedure of Webster et al.  (13), containing 0.6 per cent nitrogen  (of 
which 0.4 per cent is attributable  to hexosamine), 2 per cent phosphorus, 33 per cent lipide, 
and 65 per cent  polysaccharide was used in most of the experimental work. Incompletely 
characterized  lipopolysaccharides prepared  by  Webster  et  at.  from Hemophilus  pcrtussis, 
Shigdla .fltxncri,  Pstudomonas  acruginosa,  and  Serratia  marcesccns by the  aforementioned 
isolation procedure, with certain  modifications, were also examined. Other  lipopolysaccha- 
ride  preparations  generously  provided  by  different  investigators  included  the  following: 
from E. coU 08 and 018, S.  typhosa 0901, and rough variants  of Salmondla ¢ntcritidis and 
Salmonella schottmudlcri  (Dr. O. Westphal);  from the rough variant of S. typhosa 0901 (Dr. 
M. Raynand); from Serf. marcesccns (Dr. M. Shear); from Ps. acruginosa (Dr.  M. Usdin); 
from/~, coti 026, 055, and 0127, Serf. marcesecns and  S. typhosa 0901 (Difco Laboratories, 
Mr. H. W. Schoenlein). 
Injection  and Bleeding of Experimental  Animals.--Female albino mice of the Bagg strain, 
weighing 14 to 16 gin. were employed. Since pilot experiments had indicated  that the bio- 
logical effects produced  in mice by lipopolysaccharide injected  intravenously  or intraperi- 
toneally were essentially identical, injections were made thereafter  v/a the more convenient 
intraperitoneal  route.  The mice were exsanguinated  by bleeding directly  from  the  heart 
under  chloroform anesthesia.  Generally, 0.5  to 0.8  ml.  of blood was  obtained  from  each 
animal and blood from groups of 10 or more mice was pooled to yield a single serum speci- 
1  The term  "lipopolysaccharide"  is not intended  to imply  that such  bacterial  products 
are necessarily homogeneous or composed exclusively of polysacchatide and lipide. For the 
most  part,  these  substances,  as customarily  prepared,  also contain  nitrogenous  and  other 
associated materials in varying amount.  Until more is known about which features of chem- 
ical structure  are essential for each  or all  of the many biological properties  possessed by 
these complex materials, the terminology should be understood not to imply more than the 
foregoing. M.AURICE  LANDY  AND  LOUIS  PILLEMER  825 
men for properdin titration.  In certain instances, as many as  100  mice were employed  to 
obtain serum pools.  Serum  was frozen promptly and held at  --55°C. 
Properdin  Titrations.--Serum  samples were thawed  at  room temperature,  aliquots were 
centrifuged at 35,000  g at  2°C.  for 2  hours and the supernatants carefully decanted.  The 
untreated  serum  and  centrifuged  sample were  then  tested  for properdin  by the  zymosan 
assay (16); some samples were also tested in the bactericidal assay. All serum samples of any 
given experiment were titrated for properdin content on the same day and with the same 
reagents. 
TABLE  I 
Propwdin Levds of Mice Following Inject,ion of Lipopolysaccharides 
Effect of removal of high molecular weight substances 
Lipopolysaccharide 
derived from 
~almonella  typhosa, 
0901 
gscherichia toll, 08 
Amount injected 
i.p. 
I0 
I0 
Treatment of 
serum  pools  prior 
to  properdin 
assay 
None 
Centrifuged:~ 
None 
Centrifuged$ 
Hrs. elapsed between injection of 
lipopolysscehsride and exsanguination 
3  I  6  1,21  2,1,81  7 !12o 
Units properdin per ml. of serum* 
9 
18 
O. $ ml. of saline  None 
Centdfuged:~ 
24 
12 
24 
12 
24 
24 
! 
12  15  24  24  24 
30  36  36  36  24 
12  12  24  3030 
30  30  30  3636 
12 
12 
* Groups of 100 mice were employed to obtain the serum pools representing each product- 
time interval. 
:~ 35,000 g for 2 hours at 2°C. 
RESULTS 
In  orientation experiments on  the  properdin titers  of serum  from experi- 
mental animals  injected with  1 to  10  /zg. of bacterial lipopolysaccharides, it 
was noted that the titers were erratic and failed to show any consistent trend 
or pattern.  It had already been shown (12)  that high molecular weight poly- 
saccharides  of bacterial and  mammalian  origin combine with  properdin and 
inactivate  C'3  in  vitro.  It  was  emphasized  (12)  that  the  presence  of  these 
substances in serum interferes both with properdin and  C'3 assays and that 
high molecular weight polysaccharides first had to be removed by centrifuga- 
tion at 35,000 g in order to obtain reliable titers. 
A  series of  experiments was  carried  out to ascertain whether the removal 
of  high  molecular  weight  substances  from  serums  obtained  from  animals 
receiving  minute  amounts  of  bacterial  lipopolysaccharides  would  influence 
their  properdin  titers.  Table  I  shows  properdin  titrations  on mouse  serums 
before and after centrifugation at 35,000 g for 2 hours. It will be noted that 826  PROPEI~DXN LEVELS  AND  BACTERIAL  LIPOPOLYSACCHARIDES 
within 3  hours after administration of lipopolysaccharide  the uncentrifuged 
serum had a properdin  titer of 24 units/ml., while the same serum centrifuged 
and  the serums  of control mice  had a  titer of 12  units/ml. The results of 
previous  studies  on  the  in  vitro interaction  of  polysaccharides  with  the 
properdin system (12) suggest that a properdin-polysaccharide  complex may be 
formed at this time that would inactivate C~3 and thereby give erroneous high 
titers in the zymosan assay for properdin.  It is apparent that between 6 hours 
and approximately 3 days following administration of lipopolysaccharides  the 
untreated serums  of these  mice show lower, and at times,  erratic properdin 
values. On the other hand, after centrifugation the same serums present a con- 
sistent pattern of early rise in properdin levels reaching a maximum of approxi- 
mately 3 times normal, which is maintained for several days. Thus a series of 
events follows the injection of 10 ~,g. of lipopolysaccharide into mice, viz., during 
the first 3 hours part of the serum properdin appears to form a complex with a 
new substance  in serum which inactivates C~3. This is followed after 6 to 12 
hours by the appearance  in the blood  of high molecular  weight substances 
which interfere with the inactivation of C~3 by zymosan. These high molecular 
weight substances  persist  for 48  to 72 hours  after which  time the properdin 
levels are not altered by centrifugation. The appearance of these high molecular 
weight substances in the circulation shortly after injection of lipopolysaccharide 
suggests that they are elaborated or released by the host following stimulus or 
injury by lipopolysaccharide.  While  lipopolysaccharide  previously  has  been 
shown to combine with properdin in vitro the quantities required are of a com- 
pletely different order of magnitude inasmuch as the in vitro interactions require 
100 to 200 times the amount necessary for the described in vivo effects. 
The nature of these host products is now being investigated. Preliminary 
evidence  suggests  that they are protein-lipide--polysaccharide  complexes. In 
this connection  it is particularly significant that Shear and Perrault recently 
have succeeded in isolating polysaccharide  complexes from a variety of mam- 
malian tissues  (17) and that these also interact both in vitro and in vivo in 
diverse ways with the properdin  system (18). These results,  therefore, suggest 
that following the injection of llpopolysaccharide,  substances  are elaborated 
into the blood which interfere with the assay of properdin.  Serums containing 
these  substances  require  high speed eentrifugation, for their removal,  before 
assays are conducted. 
Effect of Lipopolysaccharides of Varied Generic Origin.--Lipopolysaccharides 
derived  from smooth and rough strains of Escherichia, Flemophilus, Pseudo- 
monas, Salmonella, Serratia, and Shigella were tested for their effect on proper- 
din levels of mice. These products were of varied generic origin and it is also 
noteworthy that they were prepared  in six different laboratories  employing 
different methods of fractionation and purification. A total of 16 products was 
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mens drawn 24 hours after intraperitoneal injection of 1 or 10 ~g.  of each of 
the  different  lipopolysaccharides  disclosed  that,  in  most  instances,  10  #g. 
elevated properdin levels and  in a  few instances even 1  ~g.  caused a  signifi- 
cant rise.  A  definitive study may well reveal quantitative  and  perhaps even 
qualitative  differences  between  these  products.  Thus  the  factor  or  factors 
responsible  for  increasing  properdin  levels  can  be  isolated  by  varied  pro- 
cedures from most Gram-negative bacterial species of both smooth and rough 
colonial types. It is again pointed out  that  these products may not be single 
chemical  entities  and  probably consist  of various  polysaccharides,  proteins, 
and lipides, differing qualitatively and quantitatively in their constitution and 
structure. 
TABLE II 
Properdin Levels of Mice Following  Injection of Lipopolysacckar~de 
Time-dose relationships 
Amount of S. typkosa 
lipopolysaccharide 
injected  i.p. 
100 
10 
1 
0.1 
0.Sml. sa~ne 
Hrs. elapsed  between injection  of lipopolysaccharide  and exsanguination 
,  I  6  I  ,21  1,8  I  72  1,2o 
Units properdin per ml. of  serum* 
18 
18 
18 
18 
18 
18 
24 
24 
18 
18 
9 
30 
24 
18 
24 
12  36 
36  36 
30  24 
18  18 
18  18 
36 
30 
24 
18 
18 
36 
24 
24 
18 
18 
* The properdin values given were obtained on serum pools from groups of ten mice at 
each dose-time combination. All sera were centrifuged for 2 hours at 3,5,000 g prior to proper- 
din assay. 
Time and Dose Relationships.--In  the foregoing sections, it was shown that 
changes  in  properdin  levels  occurred  within  a  few  hours  after  injection  of 
lipopolysaccharide.  However,  the  effect  of  the  nature  of  the  product,  the 
amount  injected  and  time  elapsed  between  injection  and  bleeding  upon  the 
character  and  magnitude  of  the  response  remained  to  be  determined.  The 
results of a  typical experiment as given in Table II show: (a)  the injection of 
100  ~g.  caused a  fall in properdin  titer between  12  and  24 hours which  was 
succeeded  by a  marked rise  which  persisted  for at  least  5  days;  the  results 
with this high dosage are essentially identical with those reported (12) earlier; 
(b)  the injection of 10 ug. produced an increase as early as 6 hours which then 
rose to a  maximum of 36 units/ml,  at 24 hours and persisted up to 72 hours. 
Attention should be called to the fact that this elevation occurred without the 
prior fall  in  properdin  titers  observed when large doses of zymosan are  em- 
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or release of properdin rather than to a mechanism which represents overcom- 
pensation "rebound" on the part of the host. (c) The effect of 1 ug. was qualita- 
tively similar to that obtained with 10 #g. except that the increase in properdin 
titer was somewhat less, (d) essentially no alteration in properdin levels occurred 
following injection of either 0.1 #g. of lipopolysaccharide or of 0.5 rnl. of saline. 
Indeed the constancy of the values in control animals  is  noteworthy. Thus, 
in the mouse, the quantity of lipopolysaccharide employed determines not only 
the rate at which properdin levels rise, but also the magnitude and duration of 
this elevation. 
In  a  subsequent  publication  (15)  it  will  be  shown  that  in  mice  treated 
identically with  those  sacrificed for properdin assay  the  degree of suscepti- 
bility  or  resistance  to  infection was  on  the  whole  related  to  the  properdin 
titers  as  here described. Thus,  the  injection of  10  #g.  of lipopolysaccharide 
resulted  in  increased  resistance  as  early  as  6  hours  and  this  resistance  to 
TABLE III 
Properdin Levds in Mice Following Challenge with Salmonella typhosa 
Trea~lent 24 hrs. 
prior to challenge 
I0 t~g. E. coli  lipopoly- 
saccharide 
).5 ml. saline 
Challenge 
50  million  S. 
typhosa Tyg.  in 
saline injected 
i.p. 
Handling of serum 
pools p.rior to 
properdin assay 
None 
Centrifuged* 
None 
Centrifuged 
Hrs. elapsed between 
Pre-  challenge and exsanguinatlon 
chal- 
lenge  [ 
3  6  I  12  18  24 
I 
Units properdin per 
ml. of serum 
18  15  18  18  24 
30  18  18  24  42 
18  18  18  12  6 
18  18  18  12  6 
30 
42 
6 
6 
* 2 hours at 35,000 g. 
challenge  (with S.  typhosa  or E. coli)  was maintained for 24 hours or more. 
As shown above, the properdin titers were elevated during this period. 
Influence of Infection on Properdin Response.--In the foregoing experiments, 
properdin  titers  were  determined  in  normal  mice.  Other  experiments  were 
undertaken  to  determine  titers  during  infection.  During  the  course of  this 
work, (15), it became apparent that the properdin levels of the animal prior to 
infection did not indicate the ability of the host to maintain this titer during 
infection. It also became clear that following the initiation of an experimental 
infection,  host-parasite  interactions  become  extremely  complex  and  the 
properdin levels during this period are altered from those of the prechallenge 
pattern. 
It  has  been observed (19)  that  properdin titers fall in mice following in- 
jection of lethal doses of viable E. coli. However, studies have not been re- 
ported  on  animals  previously  treated  with  lipopolysaccharide  and  then 
experimentally  infected.  The  results  of  one  such  experiment  (Table  III) MAURICE  LANDY  AND  LOUIS PILLES~ER  829 
shows this properdin response by the host. The data reveal that the properdin 
values for the control mice are quite unaffected by centrifugation  while  the 
properdin  levels  in  lipopolysaccharide-treated  animals  exhibit  marked  dif- 
ferences following centrifugation of serum. This shows that the production of 
endogenous high  molecular weight substances occurs in response to the lipo- 
polysaccharide stimulus or injury. Fig. 1 graphically portrays the relationship 
of the bacteriological sequence of events to  the serum properdin  alterations 
which occur following initiation of infection.  In control mice, properdin titers 
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FIG.  I.  Non-specific  resistance to infection with S.  typ~sa developed in mice following 
administration of  a  bacterial lipopolysaccharide. 
A, mice injected with 10/zg. coli lipopolymcchazide 24 hours prior to challenge; @, con- 
trol mice; --, viable count; --, properdin titer. 
remain  constant during  the period of 3  to 6 hours post  challenge.  However, 
by 12 hours,  when deaths first begin to occur, there is a  significant  drop  in 
properdin  which  in  time  becomes even  more  pronounced  as  an  increasing 
proportion  of  the  animals  become  moribund.  These  changes  are  correlated 
with  increasing  bacterial  populations  in  these  animals.  On  the  other  hand, 
mice treated with 10/~g. of coli lipopolysaccharide 24 hours prior to challenge 
exhibit  a  completely contrasting  pattern  of bacteriologic and  properdin  re- 
sponses.  Indeed at 12 to 18 hours post challenge,  at the very time when bac- 
terial populations are rapidly rising  to lethal levels and the properdin reserves 
are  being  depleted  in  the  controls,  the  lipopolysaccharide-treated  mice  are 
not  only maintaining  their  original  properdin  levels  but  these  are,  in  fact, 
increased within  12 hours to a value of 42 units,  which is extremely high  for 830  PROPERDIN  LEVELS  AND BACTERIAL  LIPOPOLYSACCHARIDES 
this species.  At the very same time bacterial multiplication is rapidly brought 
under control and the number of organisms decline to well below lethal levels. 
Thus at the time the control mice are dying rapidly, the properdin titer of the 
lipopolysaccharide-treated animals is  7  times higher than  the  controls. 
DISCUSSION 
The present work shows that the administration of a  single small dose of 
bacterial lipopolysaccharide produces alterations of major proportions in the 
properdin  level of  mice. What lends special  significance to  this observation 
is the fact that, heretofore, such elevated properdin titers had been observed 
after the administration of a variety of high molecular weight polysaccharides 
only when it had been preceded by an initial depression of properdin  titer. 
The elevation of properdin, as here reported, is not dependent upon the prior 
TABLE IV 
The Activities of Certain Products of Microbial Origin on Properdin 
Product 
Bacterial cell walls 
Bacterial lipopolysaccharides 
Dextrans 
Zymosan 
Amount required for 
Removal or i~activatlon of 8 
uuits of properdln  in vitro 
mg. 
0.5-5.0 
0.5-3.0 
1-5 
0.5-5.0 
Elevation of mouse properdin 
levels in rlro 
mg. 
0.1-1.0 
0.001-0.01 
0.2-6 
0.1-I.0 
removal of properdin by the agent injected; and perhaps may be quite un- 
related  to  this  removal.  The  data  obtained  in  time-dose  studies,  such  as 
depicted  in  Table  II,  suggest  that  rather  high  doses  of  lipopolysaccharide 
(100  #g.)  are  required  to  depress properdin  titers.  If this fall in properdin 
were  the  result  of  the  combination of properdin  and  bacterial  lipopolysac- 
charide, it would be expected that it would take place shortly after injection 
of the lipopolysaccharide. However, the data shown in Table II clearly indi- 
cate that during the first 6 hours after injection of 100  #g., properdin titers 
remain unaltered and it is not until 12 hours after injection that a pronounced 
fall in properdin concentration is observed.  This suggests that in mice even 
with a  high dose of lipopolysaccharide the fall in properdin is not caused by 
formation of complexes with the injected bacterial lipopolysaccharide. 
The large amounts of cell walls, zymosan, levans, and dextrans required to 
produce  the alterations in properdin  titer suggest that these effects may be 
qualitatively different from  the  bacterial  lipopolysaccharides. The  activities 
of these products in combining with properdin in vitro and in raising the level 
of properdin in  vivo are summarized in Table IV.  It will be seen that these 
substances have comparable activity in their interaction in vitro with proper- MAURICE  LANDY  AND  LOUIS PILLEM'ER  831 
din.  However, in their stimulation of elevated properdin levels in mice it is 
evident that, on a weight basis, the lipopolysaccharides possess activity of an 
entirely different magnitude. Inasmuch as zymosan, dextran,  and cell walls 
are  all  of  microbial  origin,  the  possibility remains  that  they may contain 
small amounts of materials resembling bacterial lipopolysaccharide which are 
actually responsible for the elevated properdin levels reported for these ma- 
terials. 
It is also noteworthy that the purified typhosa lipopolysaccharide prepared 
in this laboratory interacts with properdin but does not inactivate C'3  (12). 
However, incompletely characterized products obtained in this laboratory by 
the same basic isolation procedure were shown to inactivate C'3 in addition 
to reacting with properdin.  Since zymosan and certain dextrans, levans, and 
cell wall preparations inactivate C'3, similar inactivation by certain prepara- 
tions  of  lipopolysaccharides may  indicate  contamination  with  cellular  ma- 
terial.  The  ability  of  bacterial  lipopolysaccharides to inactivate C'3  may, 
therefore,  prove  to  be  a  useful  test  for  evaluating  the  purity  of  lipopoly- 
saccharides, or at least their freedom from certain cellular materials. 
The  appearance  of  high  molecular weight  substances  in  serum  following 
injection  of  small  amounts  of  endotoxin  is  a  highly significant,  but  unex- 
pected,  addition to  an already complex system. Indeed,  it will be  reported 
subsequently that  lipopolysaccharides evoke  similar  substances  in  man  but 
produce  high  molecular  weight  agents  in  rabbits  which  behave  quite  dif- 
ferently  (20).  The  discovery  that  different  species  elaborate  endogenous 
substances which react  differently with properdin  may yet lead  to  a  better 
understanding of antibacterial defense mechanisms, as well as the full effects 
of lipopolysaccharides in individual species. 
Even  the  limited tests  thus far completed make it clear  that while most 
lipopolysaccharides cause a  rise in properdin levels, their activity varies con- 
siderably with respect to the quantity required and the magnitude and dura- 
tion of the  effect they produce.  It remains to be  determined whether  these 
differences are  related  to  the  bacterial  species  from which  the  lipopolysac- 
charide is  derived,  to  the  cultural  conditions, or to  the  isolation procedure 
employed. 
Variations in the general endotoxic properties of bacterial lipopolysaccharides 
have also been observed by other workers and this is, in effect, a further indica- 
tion that these materials are heterogeneous and extremely difficult to charac- 
terize. Furthermore, as pointed out above, additional information on the rela- 
tionship of chemical composition to biological activity is necessary to evaluate 
these substances. On the basis of the results here obtained, it may be concluded 
that  lipopolysaccharides,  derived  from  a  number  of  bacterial  genera,  from 
numerous serotypes, from both smooth and rough strains, even though prepared 
by diverse isolation procedures have in common the ability to elevate properdin 
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The mouse generally is considered to be refractory to the endotoxic action 
of bacterial lipopolysaccharides  in that it exhibits  none of the characteristic 
syndrome elicited  in certain susceptible  species. This would  suggest  that a 
high  degree  of  susceptibility to  the  lethal  action  of  bacterial  lipopolysac- 
charides is not necessary for the observed changes in properdin concentration 
in the host. Indeed, it is noteworthy that, in mice, the increase in properdin 
levels following injection of lipopolysaccharide,  appeared  quite unrelated to 
the acute toxicity of the preparations employed. Thus, the lipopolysaccharide 
derived  from S.  typhosa  0901 is extremely toxic  (LD~o =  200  Izg.) while the 
product from E. coli 0127 is, for all practical purposes,  non-lethal (LD~o > 
5000 #g.).  Nevertheless,  the administration of 10  ~g. in each  case increa~d 
the properdin  levels from an initial value of 12 units to 36 units per ml. 
The effect of challenge with S.  typhosa  on properdin  levels in mice, previ- 
ously treated  with  lipopolysaccharide,  is  of  special  interest.  The  profound 
contrast  in  the  postchallenge  sequence  of  events  occurring  in  lipopolysac- 
charide-treated and control animals suggests that the properdin levels of animals 
prior to infection may give an incomplete picture of the host's reaction to the in- 
fective agent. Indeed, evidence presented in this report, and others to follow, in- 
dicates that the extent to which the host has been "conditioned" is of prime im- 
portance. The rapidity  and extent  with which properdin is subsequently  mobilized 
in response to the stimulus of infection may prove to be important in determining 
the fate of the host. 
SUMMARY 
The administration of a  single small  dose  of bacterial lipopolysaccharide 
produces in mice a considerable rise in properdin levels. This is accompanied 
by an early, transient, non-specific increase in resistance  to certain bacterial 
infections.  Bacterial  lipopolysaccharides  were  shown  to  possess far  greater 
activity than  other  substances  previously  studied  in bringing  about an ele- 
vation of properdin  levels. 
After the injection of bacterial lipopolysaccharides,  high molecular  weight 
substances  appear in the circulation,  which interfere  with the combination of 
properdin with zymosan and thus affect the assay of properdin. 
The  administration of  small  amounts of  bacterial  lipopolysaccharides  to 
mice  at  appropriate  times  before  experimental  infection  "conditions" the 
mice so  that they maintain normal or elevated properdin  titers during  the 
infectious process in contrast to control mice which show a progressive decline 
in properdin to low levels and death. 
The significance of this observation and its relationship  to natural resistance 
to Gram-negative  pathogens are considered. 
We  are  indebted  to  Captain  A.  Mandel,  M.S.C.,  Mr.  R.  J.  Trapani,  and  Mr.  O. 
Washington for assistance in conducting the tests in mice and to Miss L. Wurz and Mr. E. 
W. Todd for aid in carrying out properdin titrations. MAIYRICE LANDY AND LOUIS PILLEMER  833 
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